Kempen JH - Search Results

1

Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study.

Kempen JH, Daniel E, Gangaputra S, Dreger K, Jabs DA, Kaçmaz RO, Pujari SS, Anzaar F, Foster CS, Helzlsouer KJ, Levy-Clarke GA, Nussenblatt RB, Liesegang T, Rosenbaum JT, Suhler EB. Kempen JH, et al. Ophthalmic Epidemiol. 2008 Jan-Feb;15(1):47-55. doi: 10.1080/09286580701585892. Ophthalmic Epidemiol. 2008. PMID: 18300089

2

Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy.

Nguyen QD, Kempen JH, Bolton SG, Dunn JP, Jabs DA. Nguyen QD, et al. Among authors: kempen jh. Am J Ophthalmol. 2000 May;129(5):634-9. doi: 10.1016/s0002-9394(00)00356-1. Am J Ophthalmol. 2000. PMID: 10844056 Free article.

3

Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.

Kempen JH, Jabs DA, Dunn JP, West SK, Tonascia J. Kempen JH, et al. Arch Ophthalmol. 2001 Jan;119(1):33-40. Arch Ophthalmol. 2001. PMID: 11146724

4

Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, Hubbard LD. Jabs DA, et al. Among authors: kempen jh. Am J Ophthalmol. 2002 Jan;133(1):48-61. doi: 10.1016/s0002-9394(01)01322-8. Am J Ophthalmol. 2002. PMID: 11755839

5

Incremental cost effectiveness of prophylaxis for cytomegalovirus disease in patients with AIDS.

Kempen JH, Frick KD, Jabs DA. Kempen JH, et al. Pharmacoeconomics. 2001;19(12):1199-208. doi: 10.2165/00019053-200119120-00002. Pharmacoeconomics. 2001. PMID: 11772155

6

HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial.

Jabs DA, Gilpin AM, Min YI, Erice A, Kempen JH, Quinn TC; Studies of Ocular Complications of AIDS Research Group. Jabs DA, et al. Among authors: kempen jh. AIDS. 2002 Apr 12;16(6):877-87. doi: 10.1097/00002030-200204120-00007. AIDS. 2002. PMID: 11919489 Clinical Trial.

7

Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis.

Jabs DA, Martin BK, Forman MS, Hubbard L, Dunn JP, Kempen JH, Davis JL, Weinberg DV; Cytomegalovirus Retinitis and Viral Resistance Study Group. Jabs DA, et al. Among authors: kempen jh. Am J Ophthalmol. 2003 Jan;135(1):26-34. doi: 10.1016/s0002-9394(02)01759-2. Am J Ophthalmol. 2003. PMID: 12504693 Clinical Trial.

8

Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome.

Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia JA. Kempen JH, et al. Arch Ophthalmol. 2003 Apr;121(4):466-76. doi: 10.1001/archopht.121.4.466. Arch Ophthalmol. 2003. PMID: 12695243

9

The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.

Kempen JH, Martin BK, Wu AW, Barron B, Thorne JE, Jabs DA; Studies of Ocular Complications of AIDS Researh Group. Kempen JH, et al. Ophthalmology. 2003 May;110(5):987-95. doi: 10.1016/S0161-6420(03)00089-7. Ophthalmology. 2003. PMID: 12750102

10

Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome.

Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia J. Kempen JH, et al. Clin Infect Dis. 2003 Nov 15;37(10):1365-73. doi: 10.1086/379077. Epub 2003 Oct 14. Clin Infect Dis. 2003. PMID: 14583871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page